Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Teknova (Nasdaq: TKNO), a producer of critical reagents for therapy, vaccine, and molecular diagnostics development, has scheduled its fourth quarter and full year 2024 financial results announcement for March 4, 2025, after market close. The company will host a webcast and conference call at 5 p.m. Eastern Time on the same day. Investors can access the webcast through Teknova's Investor Relations website section, and participants requiring dial-in information need to register to receive a unique PIN number.
Teknova (Nasdaq: TKNO), produttore di reagenti critici per lo sviluppo di terapie, vaccini e diagnosi molecolari, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 4 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà un webcast e una conferenza telefonica alle 17:00 ora orientale dello stesso giorno. Gli investitori possono accedere al webcast attraverso la sezione Relazioni con gli Investitori del sito di Teknova, e i partecipanti che necessitano di informazioni per la chiamata devono registrarsi per ricevere un numero PIN unico.
Teknova (Nasdaq: TKNO), productor de reactivos críticos para el desarrollo de terapias, vacunas y diagnósticos moleculares, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el 4 de marzo de 2025, después del cierre del mercado. La empresa llevará a cabo un webcast y una llamada de conferencia a las 5 p.m. hora del Este ese mismo día. Los inversores pueden acceder al webcast a través de la sección de Relaciones con Inversores del sitio web de Teknova, y los participantes que requieran información para la llamada deben registrarse para recibir un número PIN único.
Teknova (Nasdaq: TKNO)는 치료, 백신 및 분자 진단 개발을 위한 중요한 시약의 생산업체로서, 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 3월 4일 시장 마감 후에 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 5시에 웹캐스트 및 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 Teknova의 투자자 관계 웹사이트 섹션을 통해 웹캐스트에 접근할 수 있으며, 전화 접속 정보를 필요로 하는 참가자는 고유한 PIN 번호를 받기 위해 등록해야 합니다.
Teknova (Nasdaq: TKNO), un producteur de réactifs critiques pour le développement de thérapies, de vaccins et de diagnostics moléculaires, a prévu d'annoncer ses résultats financiers du quatrième trimestre et de l'année complète 2024 le 4 mars 2025, après la fermeture du marché. L'entreprise organisera un webcast et une conférence téléphonique à 17h, heure de l'Est le même jour. Les investisseurs peuvent accéder au webcast via la section Relations avec les Investisseurs du site de Teknova, et les participants nécessitant des informations pour la connexion doivent s'inscrire pour recevoir un numéro PIN unique.
Teknova (Nasdaq: TKNO), ein Hersteller kritischer Reagenzien für die Entwicklung von Therapien, Impfstoffen und molekularen Diagnosen, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 für den 4. März 2025 nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 17 Uhr Eastern Time ein Webcast und eine Telefonkonferenz abhalten. Investoren können über den Bereich Investorenbeziehungen auf der Website von Teknova auf das Webcast zugreifen, und Teilnehmer, die Dial-in-Informationen benötigen, müssen sich registrieren, um eine eindeutige PIN-Nummer zu erhalten.
- None.
- None.
HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market.
Teknova will host a webcast and conference call on Tuesday, March 4, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
FAQ
When will Teknova (TKNO) release Q4 and full year 2024 earnings?
What time is Teknova's (TKNO) Q4 2024 earnings call?
How can investors access Teknova's (TKNO) Q4 2024 earnings call?
Will Teknova's (TKNO) Q4 2024 earnings call be available for replay?
